Zepp Health Corporation (ZEPP)

NYSE: ZEPP · Real-Time Price · USD

4.420

+0.070 (1.61%)

At close: Jul 30, 2026, 4:00 PM EDT

4.780

+0.360 (8.14%)

Pre-market: Jul 31, 2026, 7:48 AM EDT

Zepp Health Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	52.4	57.05	91.07	133.67	128.54	231.04
Short-Term Investments	-	-	1	5.15	4.97	3.83
Cash & Short-Term Investments	52.4	57.05	92.07	138.82	133.51	234.88
Cash Growth	-32.33%	-38.04%	-33.68%	3.98%	-43.16%	-33.20%
Accounts Receivable	56.24	66.91	62.97	60.73	98.89	84.5
Other Receivables	6.16	6.67	2.66	8.61	20.1	46.51
Total Trade Receivables	62.4	73.57	65.63	69.33	118.98	131.01
Inventory	62.84	72.76	56.79	84.89	148.15	196.56
Other Current Assets	81.62	90.15	37.08	23.69	28.26	56.02
Total Current Assets	259.26	293.53	251.56	316.73	428.91	618.47
Net Property, Plant & Equipment	7.91	7.62	10.36	15.75	24.09	38.12
Other Intangible Assets	13.21	13.61	7.09	9.87	17.87	21.33
Goodwill	9.58	9.58	9.58	9.58	9.58	9.61
Long-Term Investments	222.31	220.05	225.91	238.54	244.51	244.28
Other Long-Term Assets	20.33	20.45	24.09	45.05	38.69	25.65
Total Assets	532.6	564.84	528.59	635.52	763.66	957.46

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	59.24	80.77	51.08	37.29	66.19	207.26
Accrued Expenses	36.31	37.89	38.08	45.44	29.07	50.14
Short-Term Debt	198.09	167.45	103.53	68.68	140.4	72.66
Unearned Revenue	0.04	0.08	0.2	0.23	0.31	0.67
Other Current Liabilities	0.59	0.65	2.48	3.48	5.94	7.89
Total Current Liabilities	294.26	286.84	195.37	155.11	241.91	338.6
Long-Term Debt	40.04	59.48	75.24	120.02	99.19	114.36
Long-Term Leases	1.31	1.1	2.01	3.2	4.59	11.19
Other Long-Term Liabilities	2.82	2.88	3.25	4.44	28.73	31.78
Total Long-Term Liabilities	44.17	63.46	80.5	127.66	132.51	157.32
Total Liabilities	338.43	350.3	275.87	282.77	374.42	495.93

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.03	0.03	0.03	0.03	0.02	0.03
Treasury Stock	-16.95	-16.15	-14.99	-12.87	-9.74	-3.43
Additional Paid-in Capital	281.61	280.68	278.12	273.39	245.13	258.27
Accumulated Other Comprehensive Income	-39.43	-38.57	-40.18	-14.01	15.34	4.61
Retained Earnings	-31.09	-11.45	28.62	104.35	136.69	200
Total Common Shareholders' Equity	194.17	214.53	251.59	350.88	387.44	459.47
Minority Interest	-	-	1.14	1.87	1.8	2.06
Shareholders' Equity	194.17	214.53	252.73	352.75	389.24	461.53
Total Liabilities & Equity	532.6	564.84	528.59	635.52	763.66	957.46

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	239.44	228.03	180.78	191.9	244.18	198.2
Net Cash (Debt)	-187.04	-170.98	-88.71	-53.08	-110.67	36.67
Net Cash Growth	-	-	-	-	-	-85.17%
Net Cash Per Share	-11.72	-10.75	-5.48	-3.49	-7.19	2.22
Book Value	194.17	214.53	251.59	350.88	387.44	459.47
Book Value Per Share	12.17	13.49	15.55	23.09	25.17	27.81
Tangible Book Value	171.38	191.34	234.92	331.43	359.98	428.53
Tangible Book Value Per Share	10.74	12.03	14.52	21.81	23.39	25.94

SEC Filings: 10-K · 10-Q